Maze Therapeutics, Inc.
Total Trades
27
Buys
0
Sells
14
Largest Trade
$1M+
Insiders
5
Institutional Funds
100
Inst. Value
$1M+
Activist Filings
20
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Dandekar Atul | CSBO | SELL | $100K–$500K | 8K | $45.43 | Mar 3, 2026 |
| Dandekar Atul | CSBO | EXERCISE | $50K–$100K | 8K | $10.42 | Mar 3, 2026 |
| Bachrodt Amy | SVP, Finance | EXERCISE | $50K–$100K | 5K | $10.42 | Mar 3, 2026 |
| Bachrodt Amy | SVP, Finance | SELL | $100K–$500K | 5K | $45.20 | Mar 3, 2026 |
| Bernstein Harold | President, R&D & CMO | SELL | $500K+ | 15K | $46.02 | Feb 4, 2026 |
| Bernstein Harold | President, R&D & CMO | EXERCISE | $100K–$500K | 15K | $10.42 | Feb 4, 2026 |
| Bachrodt Amy | SVP, Finance | EXERCISE | $50K–$100K | 5K | $10.42 | Feb 4, 2026 |
| Bachrodt Amy | SVP, Finance | SELL | $100K–$500K | 5K | $46.04 | Feb 4, 2026 |
| Dandekar Atul | CSBO | SELL | $100K–$500K | 8K | $44.27 | Feb 2, 2026 |
| Dandekar Atul | CSBO | EXERCISE | $50K–$100K | 8K | $10.42 | Feb 2, 2026 |
| Bachrodt Amy | SVP, Finance | EXERCISE | $50K–$100K | 5K | $10.42 | Jan 26, 2026 |
| Bachrodt Amy | SVP, Finance | SELL | $100K–$500K | 5K | $45.52 | Jan 26, 2026 |
| Bernstein Harold | President, R&D & CMO | EXERCISE | $100K–$500K | 25K | $10.42 | Jan 9, 2026 |
| Bernstein Harold | President, R&D & CMO | SELL | $1M+ | 25K | $40.20 | Jan 9, 2026 |
| Sohn Catherine A. | Director | EXERCISE | $100K–$500K | 29K | $10.42 | Jan 8, 2026 |
| Sohn Catherine A. | Director | SELL | $1M+ | 29K | $39.07 | Jan 8, 2026 |
| Bernstein Harold | President, R&D & CMO | SELL | $100K–$500K | 5K | $40.39 | Jan 6, 2026 |
| Bernstein Harold | President, R&D & CMO | EXERCISE | $50K–$100K | 5K | $10.42 | Jan 6, 2026 |
| Bachrodt Amy | SVP, Finance | EXERCISE | $50K–$100K | 5K | $10.42 | Jan 6, 2026 |
| Bachrodt Amy | SVP, Finance | SELL | $100K–$500K | 5K | $39.15 | Jan 6, 2026 |
| Dandekar Atul | CSBO | EXERCISE | $500K+ | 73K | $10.42 | Dec 31, 2025 |
| Dandekar Atul | CSBO | SELL | $1M+ | 73K | $40.56 | Dec 31, 2025 |
| Bernstein Harold | President, R&D & CMO | SELL | $1M+ | 45K | $40.56 | Dec 31, 2025 |
| Bernstein Harold | President, R&D & CMO | EXERCISE | $100K–$500K | 45K | $10.42 | Dec 31, 2025 |
| Bachrodt Amy | SVP, Finance | EXERCISE | $100K–$500K | 15K | $10.42 | Dec 31, 2025 |
| Bachrodt Amy | SVP, Finance | SELL | $500K+ | 15K | $40.41 | Dec 31, 2025 |
| SCHELLER RICHARD H | Director | SELL | $100K–$500K | 21K | $22.37 | Sep 16, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 100 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 4.6M | $1M+ | SH |
| TRV GP IV, LLC | 4.5M | $1M+ | SH |
| Deep Track Capital, LP | 4.2M | $1M+ | SH |
| a16z Capital Management, L.L.C. | 1.7M | $1M+ | SH |
| VR Adviser, LLC | 1.5M | $1M+ | SH |
| Alphabet Inc. | 1.4M | $1M+ | SH |
| General Catalyst Group Management, LLC | 1.0M | $1M+ | SH |
| TRV GP V, LLC | 951K | $1M+ | SH |
| Logos Global Management LP | 950K | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 767K | $1M+ | SH |
| Ikarian Capital, LLC | 645K | $1M+ | SH |
| Caligan Partners LP | 550K | $1M+ | SH |
| STATE STREET CORP | 533K | $1M+ | SH |
| Squadron Capital Management LLC | 490K | $1M+ | SH |
| BESSEMER GROUP INC | 482K | $1M+ | SH |
| Matrix Capital Management Company, LP | 480K | $1M+ | SH |
| HHLR ADVISORS, LTD. | 458K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 457K | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 324K | $1M+ | SH |
| WASHINGTON UNIVERSITY | 281K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Feb 13, 2026
9.0%
4.3M shares
SC 13G/A · Feb 13, 2026
9.3%
4.5M shares
SC 13G/A · Feb 6, 2026
1.6%
784K shares
Foresite Capital Fund IV, L.P.
SC 13G/A · Nov 14, 2025
1.2%
523K shares
SC 13G/A · Nov 14, 2025
7.3%
3.2M shares
Matrix Capital Management Company, LP
SC 13G/A · Nov 13, 2025
3.5%
1.7M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Aug 14, 2025
7.7%
3.4M shares
SC 13G/A · Aug 14, 2025
6.0%
2.6M shares
SC 13G/A · Aug 14, 2025
9.0%
3.9M shares
SC 13G · May 15, 2025
9.4%
4.1M shares
Matrix Capital Management Company, LP
SC 13G · May 14, 2025
5.7%
2.5M shares
SC 13G · May 14, 2025
5.7%
2.5M shares
SC 13G · May 9, 2025
4.1%
1.8M shares
SC 13G · May 9, 2025
13.9%
6.1M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Apr 29, 2025
7.5%
3.3M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Apr 29, 2025
7.0%
3.0M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G · Feb 10, 2025
5.4%
2.4M shares
SC 13G · Feb 7, 2025
6.9%
3.0M shares
Foresite Capital Fund IV, L.P.
SC 13G · Feb 7, 2025
4.8%
2.1M shares
Foresite Capital Fund IV, L.P.
SC 13G · Feb 7, 2025
4.8%
2.1M shares